Thuja Capital
Thuja Capital invests in early stage medical product innovations
Business Model:
Revenue: $7.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Thuja Capital Information
Geographic Data
Address: Yalelaan 40
City: Utrecht
State: utrecht
Zip: 3584
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
6,195,185Website Global Rank
1,121Website Monthly Traffic
Twitter Followers
Description
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2022 | FundaMental Pharma | Seed Round | 10.4M |
| 3/2017 | NutriLeads | Series A | - |
| 1/2019 | Salvia BioElectronics | Seed Round | 2.1M |
| 10/2021 | Alveron Pharma | Seed Round | 0 |
| 5/2018 | Salvia BioElectronics | Seed Round | 1.5M |
| 8/2020 | NutriLeads | Series B | 0 |
| 11/2015 | NutriLeads | Seed Round | - |
| 12/2021 | ATRO Medical | Venture Round | 0 |
| 9/2011 | Hemics | Series A | - |
| 7/2017 | ATRO Medical | Series A | - |
| 8/2007 | Enanta Pharmaceuticals | Venture Round | - |
| 1/2008 | Cavadis | Venture Round | - |
| 12/2014 | Cristal Therapeutics | Venture Round | 7.5M |
| 8/2017 | Mellon Medical | Series B | 7.1M |
| 12/2016 | Indigo Diabetes | Series A | 0 |
| 8/2022 | AstriVax | Seed Round | 30M |
| 2/2007 | Coley Pharmaceutical Group | Post-IPO Equity | - |
| 1/2007 | Vernalis | Venture Round | - |
| 1/2007 | Avantium | Venture Round | - |
| 3/2007 | Breonics | Venture Round | - |
| 8/2007 | EpiCept Corporation | Venture Round | - |
| 2/2007 | Omrix Biopharmaceuticals | Post-IPO Equity | - |
| 6/2007 | Develogen AG | Venture Round | - |
| 12/2021 | Synerkine Pharma | Series A | 4M |
| 9/2007 | Okapi Sciences | Venture Round | - |
| 6/2007 | Ingenium Pharmaceuticals AG | Venture Round | - |
| 5/2013 | Mellon Medical | Venture Round | - |
| 8/2007 | Galapagos | Venture Round | - |
| 4/2011 | Nightbalance | Seed Round | - |
| 12/2007 | Intercell | Post-IPO Equity | - |
| 7/2013 | Nightbalance | Series A | - |
| 7/2007 | Drug Abuse Sciences | Venture Round | - |
| 1/2008 | Bioceros | Venture Round | - |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 3/2009 | DCPrime | Venture Round | - |
| 7/2016 | Nightbalance | Series B | 0 |
| 1/2010 | FABPulous | Series A | - |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 3/2019 | Synerkine Pharma | Series A | 3.7M |
| 5/2009 | Cavadis | Series A | - |
| 2/2015 | FABPulous | Series B | 0 |
| 2/2010 | arGEN-X | Series A | 4.5M |
| 4/2007 | Curacyte AG | Venture Round | - |
| 8/2011 | TheraSolve | Venture Round | - |
| 1/2015 | Hemics | Series B | - |
| 11/2008 | Okapi Sciences | Series A | 0 |
| 11/2014 | EnCare Biotech | Series A | 5.5M |
| 3/2022 | InnoSIGN | Series A | 8.1M |
| 10/2016 | MILabs | Venture Round | - |
| 3/2022 | InnoSIGN | Series A | 0 |
| 12/2021 | Synerkine Pharma | Series A | 0 |
| 12/2021 | ATRO Medical | Venture Round | 0 |
| 10/2021 | Alveron Pharma | Seed Round | 0 |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 8/2020 | NutriLeads | Series B | 0 |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 3/2019 | Synerkine Pharma | Series A | 0 |
| 1/2019 | Salvia BioElectronics | Seed Round | 0 |
| 5/2018 | Salvia BioElectronics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
